Test Your Knowledge on Postmenopausal Osteoporosis

['Paul Basilio', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] Endocrinology Advisor 2025-04-30 15:53:55

Which of the statements below about management of postmenopausal osteoporosis are correct? Read more about postmenopausal osteoporosis in our coverage of World Congress on Osteoporosis 2025. Test Your Knowledge Question 1 The effects of denosumab on bone remodeling may reverse if the drug is not taken after what period of time? 6 months 12 months 24 months 36 months Question 3 Raloxifene or bazedoxifene are recommended among postmenopausal women with osteoporosis at high risk for fracture and with which of the following patient characteristics? Question 3 Raloxifene or bazedoxifene are recommended among postmenopausal women with osteoporosis at high risk for fracture and with which of the following patient characteristics?